CoChat

Validation, kinetic modeling, and test-retest reproducibility of [ 18 F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice

Open access

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Alterations in synaptic vesicle glycoprotein 2 A (SV2A) have been associated with several neuropsychiatric and neurodegenerative disorders. Therefore, SV2A positron emission tomography (PET) imaging may provide a unique tool to investigate synaptic density dynamics during disease progression and after therapeutic intervention. This study aims to extensively characterize the novel radioligand [ 18 F]SynVesT-1 for preclinical applications. In C57Bl/6J mice ( n = 39), we assessed the plasma profile of [ 18 F]SynVesT-1, validated the use of a noninvasive image-derived input function (IDIF) compared to an arterial input function (AIF), performed a blocking study with levetiracetam (50 and 200 mg/kg, i.p.) to verify the specificity towards SV2A, examined kinetic models for volume of distribution ( V T ) quantification, and explored test-retest reproducibility of [ 18 F]SynVesT-1 in the central nervous system (CNS). Plasma availability of [ 18 F]SynVesT-1 decreased rapidly (13.4 ± 1.5% at 30 min post-injection). V T based on AIF and IDIF showed excellent agreement (r 2 = 0.95, p < 0.0001) and could be reliably estimated with a 60-min acquisition. The blocking study resulted in a complete blockade with no suitable reference region. Test-retest analysis indicated good reproducibility (mean absolute variability <10%). In conclusion, [ 18 F]SynVesT-1 is selective for SV2A with optimal kinetics representing a candidate tool to quantify CNS synaptic density non-invasively.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0271678x221101648

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Parent fraction and plasma analysis of [18F]SynVesT-1. (a) Population-based curve of intact radioligand in plasma following intraveneous injection and (b) Plasma to whole blood ratio of [18F]SynVesT-1. WB = whole blood. Data are mean ± SD. n = 3/5 per time point.
Figure 1. Parent fraction and plasma analysis of [18F]SynVesT-1. (a) Population-based curve of intact radioligand in plasma following intraveneous injection and (b) Plasma to whole blood ratio of [18F]SynVesT-1. WB = whole blood. Data are mean ± SD. n = 3/5 per time point.CC BY-NC · PubMed Central
Figure 2. Comparison of invasive and non-invasive input functions for [18F]SynVesT-1 quantification. (a) [18F]SynVesT-1 SUV time-activity curves in different brain regions during 120 min acquisition. (b) Comparison between average SUV time-activity curves for invasive (AIF) and noninvasive (IDIF) metabolite-corrected input functions during [18F]SynVesT-1 PET acquisition and (c) Pearson’s correlation between VT (IDIF) estimates based on invasive (AIF) and noninvasive (IDIF) metabolite-corrected input functions displayed excellent agreement (r2 = 0.95). Solid line represents the linear regression. n = 5. SUV = standardized uptake value.
Figure 2. Comparison of invasive and non-invasive input functions for [18F]SynVesT-1 quantification. (a) [18F]SynVesT-1 SUV time-activity curves in different brain regions during 120 min acquisition. (b) Comparison between average SUV time-activity curves for invasive (AIF) and noninvasive (IDIF) metabolite-corrected input functions during [18F]SynVesT-1 PET acquisition and (c) Pearson’s correlation between VT (IDIF) estimates based on invasive (AIF) and noninvasive (IDIF) metabolite-corrected input functions displayed excellent agreement (r2 = 0.95). Solid line represents the linear regression. n = 5. SUV = standardized uptake value.CC BY-NC · PubMed Central
Figure 3. Time stability and model comparison for [18F]SynVesT-1 quantification. VT (IDIF) estimates with different scan durations using 2TCM (a) and Logan plot (b) normalized to the values obtained with the 120 min acquisition. VT (IDIF) values based on 120 min and 60 min scan acquisition did not differ for both 2TCM (c) and Logan plot (d). Pearson’s correlation depicts the excellent agreement between VT (IDIF) based on 2TCM and Logan plot with both 120 min (e) and 60 min (f) scan acquisition. n = 10.
Figure 3. Time stability and model comparison for [18F]SynVesT-1 quantification. VT (IDIF) estimates with different scan durations using 2TCM (a) and Logan plot (b) normalized to the values obtained with the 120 min acquisition. VT (IDIF) values based on 120 min and 60 min scan acquisition did not differ for both 2TCM (c) and Logan plot (d). Pearson’s correlation depicts the excellent agreement between VT (IDIF) based on 2TCM and Logan plot with both 120 min (e) and 60 min (f) scan acquisition. n = 10.CC BY-NC · PubMed Central
Figure 4. [18F]SynVesT-1 binds specifically to SV2A in the mouse brain. (a) MR template and mean [18F]SynVesT-1 parametric maps during baseline and following blockade with levetiracetam (LEV) (i.p., 30 min before radioligand injection) overlaid onto an MRI mouse brain template for anatomical localization. (b) Average striatal SUV time-activity curve during baseline and pretreatment with levetiracetam for a 60-min acquisition. (c) Striatal [18F]SynVesT-1 VT (IDIF) (Logan) during baseline and following blockade with LEV. ****p < 0.0001 and (d) Lassen plots for target occupancy at different doses of LEV show an estimated SV2A occupancy of 97% and 100%. Baseline: n = 12. Blocking: n = 6 per dose. SUV = standardized uptake value.
Figure 4. [18F]SynVesT-1 binds specifically to SV2A in the mouse brain. (a) MR template and mean [18F]SynVesT-1 parametric maps during baseline and following blockade with levetiracetam (LEV) (i.p., 30 min before radioligand injection) overlaid onto an MRI mouse brain template for anatomical localization. (b) Average striatal SUV time-activity curve during baseline and pretreatment with levetiracetam for a 60-min acquisition. (c) Striatal [18F]SynVesT-1 VT (IDIF) (Logan) during baseline and following blockade with LEV. ****p < 0.0001 and (d) Lassen plots for target occupancy at different doses of LEV show an estimated SV2A occupancy of 97% and 100%. Baseline: n = 12. Blocking: n = 6 per dose. SUV = standardized uptake value.CC BY-NC · PubMed Central
Figure 5. [18F]SynVesT-1 binding in the spinal cord. (a) Average spinal cord SUV time-activity curve during baseline and pretreatment with levetiracetam for a 60-min acquisition. (b) [18F]SynVesT-1 VT (IDIF) (Logan) during baseline and following blockade with LEV. ****p < 0.0001 and (c) Pearson’s correlation depicts the excellent agreement between striatal and spinal quantification. Baseline: n = 12. Blocking: n = 6 per dose. SUV = standardized uptake value.
Figure 5. [18F]SynVesT-1 binding in the spinal cord. (a) Average spinal cord SUV time-activity curve during baseline and pretreatment with levetiracetam for a 60-min acquisition. (b) [18F]SynVesT-1 VT (IDIF) (Logan) during baseline and following blockade with LEV. ****p < 0.0001 and (c) Pearson’s correlation depicts the excellent agreement between striatal and spinal quantification. Baseline: n = 12. Blocking: n = 6 per dose. SUV = standardized uptake value.CC BY-NC · PubMed Central
Figure 6. Test-retest variability and reproducibility of [18F]SynVesT-1 VT (IDIF) based on 60-min acquisition. (a) Mean [18F]SynVesT-1 parametric maps during test and retest overlaid onto an MRI mouse brain template for anatomical localization. (b) Bland-Altman plot comparing test-retest VT (IDIF) estimates. The dotted lines represent the 95% limits of agreement and (c) Pearson’s correlation plot comparing test-retest VT (IDIF) estimates. The dashed line denotes the identity line. STR = striatum, THAL = thalamus, HC = hippocampus, CB = cerebellum, SC = spinal cord; n = 12.
Figure 6. Test-retest variability and reproducibility of [18F]SynVesT-1 VT (IDIF) based on 60-min acquisition. (a) Mean [18F]SynVesT-1 parametric maps during test and retest overlaid onto an MRI mouse brain template for anatomical localization. (b) Bland-Altman plot comparing test-retest VT (IDIF) estimates. The dotted lines represent the 95% limits of agreement and (c) Pearson’s correlation plot comparing test-retest VT (IDIF) estimates. The dashed line denotes the identity line. STR = striatum, THAL = thalamus, HC = hippocampus, CB = cerebellum, SC = spinal cord; n = 12.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 2

  1. Cai Z, Neurosci Lett
  2. Finnema SJ, 2017, J Cereb Blood Flow Metab, 271678X17724947

Cited by

See all 29

Metadata

Authors
Bertoglio, D., Zajicek, F., Lombaerde, S. D., Miranda, A., Stroobants, S., Wang, Y., Dominguez, C., Munoz-Sanjuan, I., Bard, J., Liu, L., Verhaeghe, J., & Staelens, S.
Affiliations
  • University of Antwerp (BE)
  • CHDI Foundation (US)
  • CHDI Management/CHDI Foundation, Los Angeles, California, USA
Corresponding author
  • Bertoglio, Daniele
  • Staelens, Steven
Venue
Journal of Cerebral Blood Flow & Metabolism
Published
2022-05-14
Volume
42
Issue
10
Pages
1867-1878
ISSN
  • 0271-678X (ISSN-L)
  • 1559-7016
OpenAlex
W4280544176
Cited by
29
References
35
Citations by year
2026: 7 · 2025: 9 · 2024: 5 · 2023: 6 · 2022: 2
FWCI
3.13
Type
journal article
Language
en
Open access
Locations
  • Journal of Cerebral Blood Flow & Metabolism (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
[18F]SynVesT-1, SV2A, image-derived input function, arterial input function, radioligand kinetics, volume of distribution, test-retest reproducibility, synaptic density, central nervous system, mice
MeSH terms
Levetiracetam, Animals, Brain, Glycoproteins, Synaptic Vesicles, Reproducibility of Results, Radiopharmaceuticals, Positron-Emission Tomography, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Validation, kinetic modeling, and test-retest reproducibility of [ 18 F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice. https://app.cochat.ai/papers/10.1177/0271678x221101648
The paper
Bertoglio, D., Zajicek, F., Lombaerde, S. D., Miranda, A., Stroobants, S., Wang, Y., Dominguez, C., Munoz-Sanjuan, I., Bard, J., Liu, L., Verhaeghe, J., & Staelens, S. (2022). Validation, kinetic modeling, and test-retest reproducibility of [ 18 F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x221101648

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.